title: Dopamine receptor agonists and levodopa and inducing psychosis-like behavior in the MPTP primate model of Parkinson disease.
authors.forename: Susan H
authors.initials: SH
authors.lastname: Fox
authors.forename: Naomi P
authors.initials: NP
authors.lastname: Visanji
authors.forename: Tom H
authors.initials: TH
authors.lastname: Johnston
authors.forename: Jordi
authors.initials: J
authors.lastname: Gomez-Ramirez
authors.forename: Valerie
authors.initials: V
authors.lastname: Voon
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Brotchie
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D002144:Callithrix; D004195:Disease Models, Animal; D018491:Dopamine Agonists / Q000008:administration & dosage*; D004333:Drug Administration Routes; D004334:Drug Administration Schedule; D007980:Levodopa / Q000008:administration & dosage*; D001523:Mental Disorders / Q000188:drug therapy* / Q000209:etiology; D020734:Parkinsonian Disorders / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D012720:Severity of Illness Index; D013997:Time Factors
chemical_list: D018491:Dopamine Agonists; D007980:Levodopa; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine